BioSpace News Archive

Business

Twenty-fifth annual BIO-Europe® to bring 4,400 life science leaders to Hamburg November 11–13

This 25th anniversary BIO-Europe® international partnering conference, November 11–13 in Hamburg, Germany, will focus on top industry visions for the next 25 years while taking a look at the most formative turning points in the past two and a half decades.

October 15, 2019
·
4 min read
Deals

Mebias Discovery Raises $3.5 Million to Expand Pipeline Using a Novel, Cell Signaling-Pathway Selective GPCR Drug Discovery Platform

Development Programs to Focus on GI and Inflammation Therapies with Reduced, or No, Side Effects

October 15, 2019
·
2 min read
Pharm Country

Poster Report Describes Loss of Functional Serpin Activity In Cancer Patient Blood

Methods to monitor the influence and potentially modulate the stromal conditioning of cancer, offers new avenues for diagnosis, personalized medicine, and therapeutic modalities.

October 15, 2019
·
5 min read
Policy

First Algenex CrisBio®-based vaccine submitted to European Medicines Agency

Potential approval would validate the use of Algenex’ CrisBio® technology for the manufacture of recombinant subunit vaccines

October 15, 2019
·
2 min read
100 young women take over BioCity

BioCity, the pioneering life science incubator and business collective opened its doors to one hundred young women from local schools on Tuesday 08 October 2019, to celebrate the tenth annual Ada Lovelace Day.

October 15, 2019
·
6 min read
ISA Pharmaceuticals B.V. receives EUR 20m loan from European Investment Bank

The European Investment Bank and ISA Pharmaceuticals have signed a EUR 20 million loan agreement to support the development of ISA’s therapy for cancers caused by the Human Papillomavirus type 16

October 15, 2019
·
4 min read
Policy

Xenikos receives FDA Fast Track designation for T-Guard® for treating steroid-refractory acute graft-versus-host disease

The Dutch company Xenikos B.V. announced that the U.S. Food and Drug Administration has granted Fast Track designation to T-Guard, Xenikos’ flagship product designed to treat steroid-refractory acute graft-versus-host disease in patients following allogeneic stem cell transplantation.

October 15, 2019
·
4 min read
Genetown

CELLINK is awarded Entrepreneur of the Year in Sweden 2019

Last Friday, CELLINK and its four co-founders were awarded the prestigious award, Entrepreneur of the Year in Sweden, 2019.

October 15, 2019
·
1 min read
Policy

ISO 9001:2015 certification for Biocair Germany

Biocair, a global leader in specialist logistics, announced that its Frankfurt office has joined the company’s network of ISO 9001:2015 certified operations.

October 15, 2019
·
2 min read
Policy

Government announces Bill to improve access to new treatments

Alzheimer’s Research UK has responded to an announcement that could see new legislation aimed at providing faster access to medicines.

October 15, 2019
·
2 min read